Skip navigation
Please use this identifier to cite or link to this item: http://repositorio.unb.br/handle/10482/6823
Files in This Item:
File Description SizeFormat 
ARTIGO_Fenofibrate-inducedRhabdomyolysis.pdf90,73 kBAdobe PDFView/Open
Title: Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease : an unusual presenting feature of hypothyroidism
Other Titles: Rabdomiólise induzida por fenofibrato em paciente com doença renal crônica : uma apresentação clínica incomum do hipotireoidismo
Authors: Sousa, Alessandra Alves de
Kronit, Hans Stauber
Neves, Francisco de Assis Rocha
Amato, Angélica Amorim
Assunto:: Rabdomiólise
Hipotireoidismo
Doença renal crônica
Fibrato
Issue Date: 2009
Citation: SOUSA, Alesandra Alves de et al. Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease: an unusual presenting feature of hypothyroidism. Arquivos brasileiros de endocrinologia & metabologia, São Paulo, v.53, n.3, p.383-386, 2009. Disponível em: <http://www.scielo.br/pdf/abem/v53n3/v53n3a15.pdf>. Acesso em: 6 jan. 2011. doi: 10.1590/S0004-27302009000300015.
Abstract: ABSTRACT: Clinical and most often moderate skeletal muscle involvement is a frequent problem in adults with hypothyroidism, and includes a number of different manifestations. Severe involvement with rhabdomyolysis, however, is very rare, and only a few cases have been reported to date, most of them with an additional factor of muscle injury. We described a patient with stage 3 chronic kidney disease who presented with rhabdomyolysis while taking fenofibrate, and was found to have hypothyroidism. We also highlighted the importance of excluding the diagnosis of thyroid dysfunction before treatment with lipid-lowering agents. _______________________________________________________________________________ RESUMO
Manifestações musculoesqueléticas variadas e de moderada intensidade são comuns em adultos com hipotireoidismo. No entanto, o envolvimento muscular grave, caracterizado por rabdomiólise, é incomum. Até o momento, poucos casos foram descritos na literatura, e a maior parte deles em associação com um fator adicional de dano muscular. Descrevemos um paciente com doença renal crônica (estádio 3) que se apresentou com rabdomiólise durante o tratamento com fenofibrato e cuja investigação adicional evidenciou hipotireoidismo primário. Enfatizamos, ainda, a importância da exclusão de disfunção tireoidiana antes de iniciar terapia com agentes hipolipemiantes.
DOI: https://dx.doi.org/10.1590/S0004-27302009000300015
Appears in Collections:Artigos publicados em periódicos e afins

Show full item record " class="statisticsLink btn btn-primary" href="/jspui/handle/10482/6823/statistics">



This item is licensed under a Creative Commons License Creative Commons